Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19
Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in […]
Surging Nanotech Investments Boost Global Healthcare and Pandemic Protection
COVID-19’s outbreak has coincided with investments flooding into nanotech-based healthcare companies, according to Pitchbook‘s latest […]
Cyber Tech Company Develops Corona Virus Digital Health Passport with VCode®
VST Enterprises Ltd (VSTE) the British cyber security company founded by tech entrepreneur Louis-James Davis […]
Stand Up Therapeutics Signed with VectorBuilder for World's First Gene Therapy Supply for Paraplegia Patient
VectorBuilder is the world’s largest supplier of customized vectors for viral and non-viral gene delivery, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more

